Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease
- PMID: 8777922
- DOI: 10.1007/BF02002715
Effects of immunoglobulin and gamma-interferon on the production of tumour necrosis factor-alpha and interleukin-1 beta by peripheral blood monocytes in the acute phase of Kawasaki disease
Abstract
In order to study the in vitro effects of intact immunoglobulin (Ig) and gamma-interferon (INF-gamma) in patients with Kawasaki disease, the production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) was measured in peripheral blood monocytes (PBM) both before and after intravenous immunoglobulin (IVIG) therapy. Spontaneous production of TNF-alpha and IL-1 beta both before and after IVIG therapy was significantly higher than in healthy controls. Intact Ig enhanced in vitro the production of TNF-alpha and IL-1 beta both before and after IVIG therapy approximately 3-4 times as compared to the spontaneous production. INF-gamma did not affect the production of the two cytokines. Ig enhanced IL-1 beta mRNA expression in PBM of KD by 3-8 times more than that of spontaneous production.
Similar articles
-
Cytokine modulation with immune gamma-globulin in peripheral blood of normal children and its implications in Kawasaki disease treatment.J Clin Immunol. 2001 May;21(3):193-9. doi: 10.1023/a:1011039216251. J Clin Immunol. 2001. PMID: 11403226
-
Increased frequency of immunoglobulin (Ig)A-secreting cells following Toll-like receptor (TLR)-9 engagement in patients with Kawasaki disease.Clin Exp Immunol. 2011 Mar;163(3):346-53. doi: 10.1111/j.1365-2249.2010.04297.x. Epub 2010 Dec 22. Clin Exp Immunol. 2011. PMID: 21175593 Free PMC article.
-
Inhibition of IL-12 synthesis of peripheral blood mononuclear cells (PBMC) stimulated with a bacterial superantigen by pooled human immunoglobulin: implications for its effect on Kawasaki disease (KD).Clin Exp Immunol. 1998 Nov;114(2):311-9. doi: 10.1046/j.1365-2249.1998.00712.x. Clin Exp Immunol. 1998. PMID: 9822292 Free PMC article.
-
[Role of ash2 (absent, small, or homeotic)-like and Jumonji domain-containing protein 3 on histone methylation of interferon-gamma gene and their associations with vascular damage of Kawasaki disease].Zhonghua Xin Xue Guan Bing Za Zhi. 2017 Sep 24;45(9):791-798. doi: 10.3760/cma.j.issn.0253-3758.2017.09.012. Zhonghua Xin Xue Guan Bing Za Zhi. 2017. PMID: 29036979 Chinese.
-
Aberrantly decreased levels of NKG2D expression in children with kawasaki disease.Scand J Immunol. 2013 May;77(5):389-97. doi: 10.1111/sji.12022. Scand J Immunol. 2013. PMID: 23298273
Cited by
-
Anti-inflammatory Treatment of Kawasaki Disease: Comparison of Current Guidelines and Perspectives.Front Med (Lausanne). 2021 Nov 30;8:738850. doi: 10.3389/fmed.2021.738850. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34917629 Free PMC article. Review.
-
Etanercept With IVIg for Acute Kawasaki Disease: A Randomized Controlled Trial.Pediatrics. 2019 Jun;143(6):e20183675. doi: 10.1542/peds.2018-3675. Epub 2019 May 2. Pediatrics. 2019. PMID: 31048415 Free PMC article. Clinical Trial.
-
IL-1 Signaling Is Critically Required in Stromal Cells in Kawasaki Disease Vasculitis Mouse Model: Role of Both IL-1α and IL-1β.Arterioscler Thromb Vasc Biol. 2015 Dec;35(12):2605-16. doi: 10.1161/ATVBAHA.115.306475. Epub 2015 Oct 29. Arterioscler Thromb Vasc Biol. 2015. PMID: 26515418 Free PMC article.
-
Dissecting Kawasaki disease: a state-of-the-art review.Eur J Pediatr. 2017 Aug;176(8):995-1009. doi: 10.1007/s00431-017-2937-5. Epub 2017 Jun 27. Eur J Pediatr. 2017. PMID: 28656474 Free PMC article. Review.
-
Profile of Urinary Cytokines in Kawasaki Disease: Non-Invasive Markers.Diagnostics (Basel). 2021 Oct 8;11(10):1857. doi: 10.3390/diagnostics11101857. Diagnostics (Basel). 2021. PMID: 34679555 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical